Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Cash from Operations (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Cash from Operations data on record, last reported at 280625000.0 in Q1 2026.

  • On a quarterly basis, Cash from Operations fell 68.77% to 280625000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 769928000.0, a 67.46% decrease, with the full-year FY2025 number at 655577000.0, down 44.84% from a year prior.
  • Cash from Operations reached 280625000.0 in Q1 2026 per PCVX's latest filing, down from 224832000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PCVX hit a ceiling of 27702000.0 in Q1 2022 and a floor of 280625000.0 in Q1 2026.
  • A 5-year average of 109189176.47 and a median of 111401000.0 in 2024 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 13.52% in 2024 and fell as far as 233.66% in 2024.
  • Tracing PCVX's Cash from Operations over 5 years: stood at 65221000.0 in 2022, then crashed by 97.5% to 128810000.0 in 2023, then grew by 13.52% to 111401000.0 in 2024, then plummeted by 101.82% to 224832000.0 in 2025, then decreased by 24.82% to 280625000.0 in 2026.
  • Business Quant data shows Cash from Operations for PCVX at 280625000.0 in Q1 2026, 224832000.0 in Q4 2025, and 143305000.0 in Q3 2025.